Vardenafil

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1349 publications

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis.

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis.

Journal: Hospital pharmacy

Published: May 22, 2026

Evaluation of vardenafil's metabolic stability in human liver microsomes through ultra-fast UPLC-MS/MS for quantitative analysis, including assessments of greenness, ADME properties, DEREK alerts, and metabolic lability.

Evaluation of vardenafil's metabolic stability in human liver microsomes through ultra-fast UPLC-MS/MS for quantitative analysis, including assessments of greenness, ADME properties, DEREK alerts, and metabolic lability.

Journal: The Analyst

Published: May 14, 2026

In brief: Vybrique - sildenafil oral film for erectile dysfunction.

In brief: Vybrique - sildenafil oral film for erectile dysfunction.

Journal: The Medical letter on drugs and therapeutics

Published: May 02, 2026

Molecularly imprinted dual-function ion source for direct and sensitive ambient mass spectrometric detection of trace vardenafil in medicinal liquor.

Molecularly imprinted dual-function ion source for direct and sensitive ambient mass spectrometric detection of trace vardenafil in medicinal liquor.

Journal: Analytical and bioanalytical chemistry

Published: March 09, 2026

Synergistic relaxation of ureteral smooth muscle by doxazosin and vardenafil: experimental implications for medical expulsive therapy.

Synergistic relaxation of ureteral smooth muscle by doxazosin and vardenafil: experimental implications for medical expulsive therapy.

Journal: International urology and nephrology

Published: March 08, 2026

The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein.

The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: February 17, 2026

Effect of vardenafil in long-standing diabetic patients comparing different doses regarding erectile dysfunction, testosterone level and partner satisfaction.

Effect of vardenafil in long-standing diabetic patients comparing different doses regarding erectile dysfunction, testosterone level and partner satisfaction.

Journal: Arab journal of urology

Published: January 09, 2026

Vardenafil Ameliorates Hypertension-Induced Erectile Dysfunction by Suppressing the HMGB1/RAGE/NF-κB Pathway.

Vardenafil Ameliorates Hypertension-Induced Erectile Dysfunction by Suppressing the HMGB1/RAGE/NF-κB Pathway.

Journal: Urology

Published: December 22, 2025

Spatial and Temporal Tracking of Counterfeit Phosphodiesterase Type V Inhibitors Use Based on Wastewater Analysis.

Spatial and Temporal Tracking of Counterfeit Phosphodiesterase Type V Inhibitors Use Based on Wastewater Analysis.

Journal: Environmental science & technology

Published: December 10, 2025

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials.

A comparative evaluation of on-demand phosphodiesterase-5 inhibitor efficacy in erectile dysfunction treatment: a systematic review and network meta-analysis of double-blind, placebo-controlled, randomized trials.

Journal: The journal of sexual medicine

Published: December 08, 2025

Vardenafil in the multidisciplinary management of erectile dysfunction: a narrative review on multidimensional outcomes and clinical integration.

Vardenafil in the multidisciplinary management of erectile dysfunction: a narrative review on multidimensional outcomes and clinical integration.

Journal: World journal of urology

Published: November 16, 2025

Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential.

Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential.

Journal: Bone reports

Published: November 02, 2025

Showing 1-12 of 1,349

Last Updated: 06/30/2026